← Research Library
05 / RESEARCH AREA
ENDOCRINE · GROWTH AXES · RECEPTOR SIGNALING

Endocrine & Growth Signalling

Profiles grouped around endocrine signalling, pituitary and growth-factor pathways, recompoundive-axis research and receptor biology.

Profiles are grouped here by research topic and may overlap with other scientific areas. Evidence-status wording is carried over from the underlying ENHANCED profile and is not a ranking of efficacy, safety or suitability.
Extensive human clinical literature10,000 IU

HCG

HCG is a glycoprotein hormone studied in research involving LH-receptor signalling and recompoundive-endocrine pathways.

Research focus: LH-receptor and recompoundive-endocrine research

VIEW FULL RESEARCH PROFILE ↗
Human translational research10mg

Kisspeptin

Kisspeptin is studied in research involving KISS1R signalling and regulation of the hypothalamic-pituitary-gonadal axis.

Research focus: KISS1R and recompoundive-axis research

VIEW FULL RESEARCH PROFILE ↗
Primarily experimental research1mg

IGF-1 LR3

IGF-1 LR3 is a long-acting IGF-1 analogue explored in research involving IGF-1 receptor signalling and growth-factor pathways.

Research focus: IGF-1 receptor and growth-factor research

VIEW FULL RESEARCH PROFILE ↗
Established human clinical literature10mg

Tesamorelin

Tesamorelin is a GHRH analogue studied in research involving growth-hormone signalling, IGF-1 pathways and body-composition biology.

Research focus: GHRH analogue and metabolic research

VIEW FULL RESEARCH PROFILE ↗
Early human and preclinical research10mg

Ipamorelin

Ipamorelin is a selective growth-hormone secretagogue studied in research involving ghrelin-receptor signalling and pulsatile GH release.

Research focus: Growth-hormone secretagogue research

VIEW FULL RESEARCH PROFILE ↗
Limited human clinical research10mg

CJC 1295 + DAC

CJC 1295 + DAC is a longer-acting GHRH analogue explored in research involving growth-hormone and IGF-1 signalling.

Research focus: Longer-acting GHRH analogue research

VIEW FULL RESEARCH PROFILE ↗
Component evidence varies10mg

CJC 1295 NO DAC + Ipamorelin

This blend pairs a GHRH analogue with a growth-hormone secretagogue for research involving coordinated GH-pathway signalling.

Research focus: Combined GHRH and secretagogue research

VIEW FULL RESEARCH PROFILE ↗
Established human clinical literature10mg

PT-141

PT-141, also known as bremelanotide, is explored in research involving central melanocortin-receptor signalling.

Research focus: Melanocortin-receptor research

VIEW FULL RESEARCH PROFILE ↗
Blend-specific evidence required80mg

KLOW

KLOW is supplied as an 80mg research blend. Refer to the supplied compound documentation for composition and compound-specific research context.

Research focus: Research-blend presentation

VIEW FULL RESEARCH PROFILE ↗